Generic Name and Formulations:
Sodium hyaluronate 10mg/mL; soln for intra-articular inj.
Ferring Pharmaceuticals, Inc.
Indications for EUFLEXXA:
Osteoarthritis of the knee in patients who have failed nonpharmacologic therapy and analgesics (eg, acetaminophen).
Prior to treatment: remove joint effusion (use separate syringe), if present. Inject 2mL (full syringe contents) intra-articularly in each affected knee weekly for 3 weeks. Use separate syringes for each knee.
Knee joint infection or skin disease at inj site.
Repeated treatment cycles: not established. Avoid intravascular injection. Avoid strenuous activity within 48hrs after injection. Pregnancy. Nursing mothers.
Avoid disinfectants with quaternary ammonium salts. Concomitant other intra-articular injectables: not recommended.
Arthralgia, increase blood pressure, inj site pain, local reactions, transient knee inflammation.
Single-use prefilled syringes (2mL)—1